Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Prophylaxis With PEG-rhG-CSF Versus Therapeutic Short-Acting rhG-CSF for Neutropenia During and After Pelvic Chemoradiotherapy in Patients With Cervical or Endometrial Cancer: A Randomized Controlled Trial

NCT07865650 is registered in ClinicalTrials.gov with The Second Hospital of Anhui Medical University as lead sponsor.

NCT NCT07865650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07865650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Prophylaxis With PEG-rhG-CSF Versus Therapeutic Short-Acting rhG-CSF for Neutropenia During and After Pelvic Chemoradiotherapy in Patients With Cervical or Endometrial Cancer: A Randomized Controlled Trial
Lead sponsor
The Second Hospital of Anhui Medical University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 15, 2026
Completion date
December 31, 2028
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, endometrial cancer